Audentes therapeutics, inc. (BOLD)
Balance Sheet / Yearly
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Dec'15
Assets
Current assets:
Cash and cash equivalents

63,600

99,000

133,160

144,349

104,339

214,495

230,864

38,967

53,531

54,574

18,764

36,359

87,067

12,456

72,058

Short-term investments

287,874

279,643

236,344

269,958

176,347

99,939

95,264

94,638

102,514

90,434

62,964

68,524

32,113

42,802

23,169

Restricted cash

-

-

-

-

-

-

90

90

820

820

820

730

1,242

5,438

730

Prepaid expenses and other current assets

4,919

14,203

3,651

5,465

4,642

4,997

3,155

3,315

3,667

3,563

3,358

2,824

4,846

8,579

3,682

Total current assets

356,383

392,841

373,155

419,772

285,328

319,431

329,373

137,010

160,532

149,391

85,906

108,437

125,268

69,275

99,639

Restricted cash - long-term

3,748

3,748

3,748

3,748

3,604

3,604

3,604

3,604

3,280

3,280

3,280

3,020

2,930

2,930

2,930

Long-term investments

-

-

5,517

-

1,252

-

-

-

-

-

-

-

-

-

-

Property and equipment, net

38,165

37,467

34,731

32,099

30,653

29,340

26,436

24,372

22,759

22,245

19,489

18,936

18,885

16,653

2,968

Right-of-use assets

24,900

25,600

21,089

-

-

-

-

-

-

-

-

-

-

-

-

Goodwill

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

3,631

Intangible assets

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

8,000

Other assets

6,722

6,850

5,305

5,305

5,305

2,045

2,045

2,045

2,045

2,045

1,433

33

36

36

301

Total assets

441,508

478,114

455,176

472,555

337,773

366,051

373,089

178,662

200,247

188,592

121,739

142,057

158,750

100,525

117,469

Liabilities and Stockholders' Equity
Current liabilities:
Accounts payable

9,905

7,181

11,811

8,123

3,224

4,959

5,301

3,853

4,656

4,009

1,506

2,424

2,725

4,302

2,789

Accrued liabilities

14,550

16,897

11,520

12,928

15,580

11,384

8,049

8,832

8,505

10,709

7,063

9,871

7,112

7,823

4,797

Operating lease liabilities

3,399

3,247

2,773

-

-

-

-

-

-

-

-

-

-

-

-

Contingent acquisition consideration payable

0

0

0

2,345

-

-

2,359

4,643

-

-

-

-

-

-

-

Deferred rent

-

-

0

456

442

424

410

384

175

137

134

265

-

-

137

Facility lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

307

383

-

Total current liabilities

27,854

27,325

26,104

23,852

19,246

16,767

16,119

17,712

13,336

14,855

8,703

12,560

10,144

12,508

7,723

Deferred rent - long-term

-

0

0

4,720

-

-

-

-

-

-

-

-

-

-

-

Asset retirement obligation - long-term

231

226

221

215

-

-

-

-

-

-

-

-

-

-

-

Operating Lease, Liability, Noncurrent

26,490

27,444

23,519

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent and asset retirement obligation - long-term

-

-

-

-

4,590

4,951

3,454

3,278

3,789

3,879

2,778

2,486

-

-

519

Facility lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

2,411

2,418

-

Contingent acquisition consideration payable - long-term

2,460

2,403

2,323

0

2,316

2,300

-

-

4,540

4,544

4,470

4,380

4,574

4,460

4,278

Deferred tax liability, net

1,014

1,014

1,014

1,014

1,014

1,014

1,014

1,014

3,260

3,260

3,260

3,260

3,260

3,260

3,260

Other long-term liabilities

-

-

-

-

52

55

60

60

-

-

-

-

-

-

-

Total liabilities

58,049

58,412

53,181

29,801

27,218

25,087

20,647

22,064

24,925

26,538

19,211

22,686

20,389

22,646

15,780

Stockholders' equity:
Preferred stock, $0.00001 par value, 10,000,000 shares authorized as of September 30, 2019 (unaudited) and December 31, 2018; 0 shares issued and outstanding as of September 30, 2019 (unaudited) and December 31, 2018, respectively

0

0

0

0

0

0

0

-

0

0

0

0

0

-

0

Common stock, $0.00001 par value, 300,000,000 shares authorized as of September 30, 2019 (unaudited) and December 31, 2018; 45,740,575 and 43,546,786 shares issued and outstanding as of September 30, 2019 (unaudited) and December 31, 2018, respectively

0

0

0

0

0

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

842,599

833,101

770,789

762,284

594,480

588,594

568,756

347,327

341,613

303,356

221,083

219,811

219,098

7,492

6,692

Retained Earnings (Accumulated Deficit)

-459,400

-413,600

-368,861

-319,470

-283,878

-247,587

-216,220

-190,649

-166,274

-141,265

-118,526

-100,411

-80,735

-65,366

-40,743

Accumulated other comprehensive income (loss)

226

226

67

-60

-47

-43

-94

-80

-17

-37

-29

-29

-2

3

-10

Total stockholders' equity

383,459

419,702

401,995

442,754

310,555

340,964

352,442

156,598

175,322

162,054

102,528

119,371

138,361

77,879

101,689

Total liabilities and stockholders' equity

441,508

478,114

455,176

472,555

337,773

366,051

373,089

178,662

200,247

188,592

121,739

142,057

158,750

100,525

117,469